Form 4 for ALLR Allarity Therapeutics, Inc.
Accepted 2024-10-01 00:00:00 ET · period of report 2024-09-30 · accession 0001213900-24-084163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-01 | 2024-09-30 | ALLR | Graff Jeremy R. | See Remarks | A - Grant | $2.11 | +118.5K | 118.5K | New | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | A | A | 118,483 | $2.11 | 118,483 | D | — | — | (F1) The Reporting Person was granted 118,483 restricted stock units, or RSUs, in connection with the Reporting Person's appointment as President and Chief Development Officer of the Issuer. The RSUs will vest in equal one-third installments on the first, second, and third anniversary of the Reporting Person's appointment, subject to the Reporting Person's continued relationship with the Issuer through each such date. |